EUVIMEDEUVIMED entdecken
Crossref

Enhanced Gut-to-Liver Oral Drug Delivery via Ligand-Modified Nanoparticles by Attenuating Protein Corona Adsorption

Jie Wang, Zilong Zhang, Zhuan Zhang, Zhiwen Zou, Yan Zhuo, Chang Liu, Di Nie, Yong Gan iD, Miaorong Yu iD

ACS Nano · 2024

DOI: 10.1021/acsnano.4c11453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Jie Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Hauptthemen laut MEDLINE: Nanoparticles, Protein Corona, Liver, Drug Delivery Systems. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: China Association for Science and Technology, National Key Research and Development Program of China, Shanghai Institute of Materia Medica, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesProtein CoronaLiverDrug Delivery SystemsDrug CarriersAnimalsAdministration, OralMiceAdsorptionLigandsReceptors, FcSilicon DioxideHumansDiabetes Mellitus, ExperimentalMaleHistocompatibility Antigens Class IMice, Inbred C57BLExenatide

Stichwörter der Autor:innen

ligand-modified nanoparticlesliver targetingmucusoral deliveryprotein corona

Substanzen

Protein CoronaLigandsReceptors, FcSilicon DioxideFc receptor, neonatalHistocompatibility Antigens Class IExenatideDrug Carriers

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, National Institutes for Food and Drug Control, Beijing 100050, China.

ORCID-Profile: Yong Gan, Miaorong Yu

Förderung

  • China Association for Science and Technology
  • National Key Research and Development Program of China
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • National Science Fund for Distinguished Young Scholars
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • Shanghai Action Plan for Science, Technology, and Innovation
  • Key Technology Program for Nucleic Acid Drugs of NCTIB

Zitieren

APA

Wang, J., Zhang, Z., Zhang, Z., Zou, Z., Zhuo, Y., Liu, C., Nie, D., Gan, Y., & Yu, M. (2024). Enhanced Gut-to-Liver Oral Drug Delivery via Ligand-Modified Nanoparticles by Attenuating Protein Corona Adsorption. ACS Nano. https://doi.org/10.1021/acsnano.4c11453

Vancouver

Wang J, Zhang Z, Zhang Z, Zou Z, Zhuo Y, Liu C, et al. Enhanced Gut-to-Liver Oral Drug Delivery via Ligand-Modified Nanoparticles by Attenuating Protein Corona Adsorption. ACS Nano. 2024. doi:10.1021/acsnano.4c11453

BibTeX
@article{Wang2024,
  author = {Wang, Jie and Zhang, Zilong and Zhang, Zhuan and Zou, Zhiwen and Zhuo, Yan and Liu, Chang and Nie, Di and Gan, Yong and Yu, Miaorong},
  title = {Enhanced Gut-to-Liver Oral Drug Delivery via Ligand-Modified Nanoparticles by Attenuating Protein Corona Adsorption},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.4c11453}
}
Kostenlos starten →